How we operate
An AI-native biotech.
We did not add AI to a biotech. We are building the company around it, with humans holding the judgment and AI amplifying the work.
ArrowBiome is a biotechnology company, not a digital-services company. Our products are precision microbiome actives, grounded in science and clinical evidence. What sets how we operate apart is that we have reorganised the company around AI from the start: a small, senior team that delivers the scope of a much larger one, with humans firmly in the loop on every decision that matters.
The operating model
Human-led, AI-amplified.
Humans hold the judgment
Our people bring the curiosity, context, and strategic vision: asking the right questions, weighing real-world stakes, and deciding what is worth doing. Direction and accountability stay with humans, always.
AI amplifies the work
AI scans research landscapes, drafts, synthesises, and surfaces weak signals at a speed and scale no small team could match. It prepares the briefing; it does not make the call.
Every output crosses a human
Nothing leaves the company without human review. AI accelerates the first 80 percent; our experts own the judgment, verification, and the final word.
What has changed
Measured leverage, honestly framed.
the scope of a larger team, delivered by a small one, with cost discipline
qualification, stability interpretation, and INCI preparation
internal pre-work ahead of external legal and regulatory review
These are internal before-and-after observations over twelve months of operating, not peer-benchmarked figures or guarantees. We treat them as foresight, not forecast: we measure, and we adjust.
Compliance-first by design
Your data, and ours, stays inside.
We applied compliance thinking to our architecture from day one. Work that touches proprietary knowledge, formulations, clinical results, IP, and customer relationships, is handled on our own infrastructure: nothing leaves. External, public information is handled with enterprise-grade tools. Partners and brand owners know exactly where their queries go, and our proprietary microbiome data, not any off-the-shelf model, is the asset behind it.
Where we are, honestly
A working operating model. Productising next.
We are honest about the gap. We have a working AI operating model embedded in how we work day to day. We have not yet fully productised or scaled the internal stack: that is the focus of the next twelve months. We are not selling a promise. We are building a defensible operating model, and correcting course as we learn.